493 related articles for article (PubMed ID: 17332339)
1. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
2. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
3. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
4. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
Repasky GA; Zhou Y; Morita S; Der CJ
Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
6. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
7. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Ras transformation of human thyroid epithelial cells.
Poghosyan Z; Wynford-Thomas D
Methods Enzymol; 2006; 407():648-60. PubMed ID: 16757359
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells.
Agbunag C; Bar-Sagi D
Cancer Res; 2004 Aug; 64(16):5659-63. PubMed ID: 15313904
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
[TBL] [Abstract][Full Text] [Related]
12. R-Ras promotes tumor growth of cervical epithelial cells.
Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
[TBL] [Abstract][Full Text] [Related]
13. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.
Giehl K; Skripczynski B; Mansard A; Menke A; Gierschik P
Oncogene; 2000 Jun; 19(25):2930-42. PubMed ID: 10871844
[TBL] [Abstract][Full Text] [Related]
14. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
16. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.
Lee SG; Su ZZ; Emdad L; Sarkar D; Franke TF; Fisher PB
Oncogene; 2008 Feb; 27(8):1114-21. PubMed ID: 17704808
[TBL] [Abstract][Full Text] [Related]
18. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
19. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
20. Activation of Raf-1 in human pancreatic adenocarcinoma.
Berger DH; Jardines LA; Chang H; Ruggeri B
J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
